UBS Group
RPRX

UBS Group’s Repros Therapeutics Inc. RPRX Stock Holding History

UBS Group’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-100
Closed -$1K – 10274
2014
Q4 		$1K Buy
+100
New +$853 ﹤0.01% 9656

UBS Group's RPRX Position: Q1 2018 in Review

UBS Group sold out of Repros Therapeutics Inc. (RPRX) in Q1 2018, closing a stake of 23,781 shares — an estimated $16K sold.

UBS Group first reported a position in RPRX in Q4 2014 and held it in 13 quarters. The position peaked at $55K in Q4 2014. 1 fund tracked by Wall St. Rank holds RPRX as of Q1 2018.

  • UBS Group reported no remaining Repros Therapeutics Inc. position as of Q1 2018 after selling out during the quarter.
  • UBS Group sold 23,781 Repros Therapeutics Inc. shares in Q1 2018, an estimated $16K.
  • UBS Group first reported a position in Repros Therapeutics Inc. in Q4 2014 and held it in 13 quarters.
  • UBS Group's Repros Therapeutics Inc. position peaked at $55K in Q4 2014.
  • 1 fund tracked by Wall St. Rank held Repros Therapeutics Inc. as of Q1 2018.

Based on UBS Group's 13F filing for Q1 2018, filed 15 May 2018.